Emilio Cordova
Directeur Général chez SAMDI Tech, Inc.
Profil
Emilio Cordova is currently the Chief Executive Officer at SAMDI Tech, Inc. since 2015.
Prior to this, he worked as the Vice President-Business Development at Inotiv, Inc.
Postes actifs de Emilio Cordova
| Sociétés | Poste | Début |
|---|---|---|
SAMDI Tech, Inc.
 SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million. | Directeur Général | 01/01/2015 |
Anciens postes connus de Emilio Cordova
| Sociétés | Poste | Fin |
|---|---|---|
| INOTIV, INC. | Corporate Officer/Principal | 01/10/2008 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INOTIV, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
SAMDI Tech, Inc.
SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million. | Health Technology |
